Data: 08/08/2026
Total encontrado: 6
1/6Câncer
Costa S. Medeiros R, Schmitt F. DNA signalling/repair genetic polymorphisms and breast cancer risk: a review. Applied Cancer Research, São Paulo: Tecmedd, v.25, n.4, p. 161-180, 2005. ISSN 1808-5512.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR200525p.161-180.pdf

DNA REPAIR; DNA DAMAGE; POLYMORPHISM; GENETEC; BREAST NEOPLASMS


2/6Câncer
Sampaio EBM, Albuquerque IMN, Linhares JJ. Assessing the Quality of Life in Women with Breast Cancer Through the Questionnaire SF-36. Applied Cancer Research, São Paulo: Tecmedd, v.28, n.3, p. 93-8, 2008. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR200828p.93-98.pdf

QUALITY OF LIFE; QUESTIONNAIRES; BREAST NEOPLASMS; MAMMOGRAPHY


3/6Câncer
Oliveira Filho V, De Luca LA, Del Giglio A, Grespan RMZ, Stephan AB, Bali H, Oliani HBS, Góes JCS. Serum Zinc Levels and Breast Intraductal Neoplasm. Applied Cancer Research, São Paulo: Tecmedd, v.28, n.4, p. 144-7, 2008. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR200828p.144-7.pdf

BREAST NEOPLASMS; ZINC


4/6Câncer
Queiroz GS, Santos AFR, Pereira RJ, Pereira GLH,Freitas-Junior R. Prevalence of paresthesia, fatigue, edema and pain after treatment for breast cancer. Applied Cancer Research, São Paulo: Tecmedd, v.29, n.4, p. 173-8, 2009. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR2009294p.173-8.pdf

BREAST NEOPLASMS; FATIGUE; PAIN EDEMA; TREATMENT OUTCOME


5/6Câncer
Rocha RM, Miller K, Soares F, Vassallo J, Shenka N, Gobbi H. The use of the immunohistochemical biotin-free visualization systems for estrogen receptor evaluation of breast Cancer. Applied Cancer Research, São Paulo: Tecmedd, v.29, n.3, p. 112-7, 2009. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR2009293p.112-7.pdf

IMMUNOHISTOCHEMISTRY; BREAST NEOPLASMS; ESTROGEN RECEPTOR


6/6Câncer
Safar ASS, Pelloso SM, Wielewski S, Kasimerczak AR, de Lima ANZ, ITS Previdelli. Immunohistochemical study of ER, PR and HER2 expression in obese and non-obese menopausal women with breast cancer. Applied Cancer Research, São Paulo: Tecmedd, v.29, n.3, p. 125-8, 2009. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR2009293p.125-8.pdf

BREAST NEOPLASMS; OBESITY; MENOPAUSE; IMMUNOHISTOCHEMICAL; ESTROGEN REPLACEMENT THERAPY